Renown Institute for Heart & Vascular Health 2022 Annual Report | Page 8

Average time between referral to procedure is less than three weeks .

Structural Heart

Created in 2015 , Renown Health ’ s Structural Heart Program is the first integrated program of its kind in northern Nevada to provide specialized care to patients with complex and progressive structural heart and valve disease . Our dedicated team of experts – including award-winning interventional cardiologists , board-certified cardiac surgeons , highly trained imaging specialists and more – offers comprehensive diagnostics , advanced treatment options and leading-edge technologies .
Revolutionary Structural Heart Procedures
The Structural Heart Program leads the region in treatment for structural heart disease patients , specializing in transcatheter – minimally invasive – heart valve repair and replacement procedures . While open-heart surgery may be the best treatment option in some heart disease cases , these minimally invasive techniques have made care easier for patients , with faster recovery times and fewer complications . Our team has performed more than 900 transcatheter procedures since the program started .
Procedural Offerings
• Transcatheter Aortic Valve Replacement ( TAVR )
• Mitral Valve Transcatheter Edge-To-Edge repair ( TEER )
• Transcatheter Valve-in-Valve Replacement
• Mitral and Aortic Balloon Valvuloplasty
• Patent Foramen Ovale ( PFO )
• Simple and complex Atrial Septal Defect ( ASD ) repair
• Paravalvular Leak Closure ( PVL )
Clinical Offerings
• Valve echo surveillance
• Structural heart patient education
• Comprehensive valve workup

FACT :

Average time between referral to procedure is less than three weeks .
• Multidisciplinary patient reviews
Leader in TAVR
Renown Health was the first in the region to offer patients Transcatheter Aortic Valve Replacement ( TAVR ). This advanced treatment is a minimally invasive procedure that treats aortic stenosis , a progressive disease that affects the aortic valve of the heart . During the procedure , a new valve is inserted within the diseased aortic valve while the heart is still
8